SANTERO
Brussels, BE · Founded 2021 · 24 employees on LinkedIn · 1 known investors
Santero is a Belgium-based biotech company developing antibacterial drugs, including an RSH inhibitor programme targeting Pseudomonas aeruginosa and multidrug-resistant pathogens. It runs drug discovery and preclinical development spanning computational chemistry, medicinal chemistry, and screening toward clinical development.
Founders & leadership
SANTERO was founded in 2021 by Abel Garcia-Pino and Cédric Govaerts.
Investors · 1
Frequently asked questions
- What does SANTERO do?
- Santero is a Belgium-based biotech company developing antibacterial drugs, including an RSH inhibitor programme targeting Pseudomonas aeruginosa and multidrug-resistant pathogens. It runs drug discovery and preclinical development spanning computational chemistry, medicinal chemistry, and screening toward clinical development.
- Who founded SANTERO?
- SANTERO was founded by Abel Garcia-Pino, Cédric Govaerts in 2021.
- Who are SANTERO's investors?
- SANTERO's investors include Newton Biocapital.
- Where is SANTERO headquartered?
- SANTERO is headquartered in Brussels, BE.